Burlington-based LabCorp, a leader in COVID-19 testing, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration to deploy an improved laboratory test for detecting ...
Burlington-based LabCorp has developed the first testing method to simultaneously detect for COVID-19, influenza A / B, and respiratory syncytial virus (RSV) just in time for the upcoming flu season.
The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results